Screener
Solventum SOLV MedSurg — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solventum in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Solventum’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:27 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001964738-26-000047
| Net Sales (Millions) | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Total net sales | $2,209 | $2,161 | $4,216 | $4,231 |
| Three months ended June 30, | Six months ended June 30, | |||
| Cost of Sales (Millions) | 2026 | 2025 | 2026 | 2025 |
| MedSurg | $595 | $603 | $1,217 | $1,151 |
| Dental Solutions | 124 | 113 | 243 | 231 |
| Health Information Systems | 82 | 91 | 162 | 179 |
| Three months ended June 30, | Six months ended June 30, | |||
| Operating Expenses (Millions)* | 2026 | 2025 | 2026 | 2025 |
Item 1. Financial Statements
FAQ
- What is Solventum's medsurg — cost of sales?
- Solventum (SOLV) reported medsurg — cost of sales of $595M in Q2 2026.
- How has Solventum's medsurg — cost of sales changed year-over-year?
- Solventum's medsurg — cost of sales decreased by 1.3% year-over-year, from $603M to $595M.
- What is the long-term trend for Solventum's medsurg — cost of sales?
- Over 3 years (2022 to 2025), Solventum's medsurg — cost of sales has grown at a 4.9% compound annual growth rate (CAGR), from $2.09B to $2.41B.
- What does medsurg — cost of sales mean?
- Includes the direct costs associated with manufacturing and delivering the products sold by the MedSurg segment, such as raw materials, direct labor, and manufacturing overhead. It is a key measure of the segment's production efficiency and supply chain management.
Ask your AI about Solventum's medsurg — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude